View the PROSPECT II and PROSPECT ABSORB study results as presented at TCT Connect.LEARN MORE LEARN MORE
Register for the CME-accredited virtual webinar “New Avenues for the Detection and Treatment of Vulnerable Plaque,” hosted by Mount Sinai Heart, to learn new and emerging approaches in the detection, management and treatment of vulnerable plaque.
Infraredx, a Nipro Company holds several United States and Foreign patents for the Makoto™ Imaging System
| US Patent Number/Application Number | Foreign Patents |
|---|---|
| 7486985 | EU: 03767194 |
| 7376456 | EU: 06816136 |
| 8060187 B2 | EU: 1636627 |
| 7450241 | EU:1601288 |
| 7426410 | EU: 2174686 |
| 7679754 | EU: 1667576 |
| 7672713 | JP: 4602765 |
| 6654630 B2 | JP: 5064796 |
| 7873406 | JP: 4965803 |
| 6873868 | JP: 4170771 |
| 7742805 | JP: 4972407 |
| 6706004 | JP: 2010-120418 |
| 6701181 | JP: 2013-264566 |
| 6615062 | JP: 2012-187282 (Pending) |
| 6904072 | |
| 6949072 | |
| 6904199 | |
| 7616321 | |
| 6895137 | |
| 7996069 | |
| 7292715 | |
| 7310357 | |
| 7313432 | |
| 8280495 | |
| 7929145 |
© 2020 Infraredx™, Inc. All Rights Reserved Powered by Bloom Creative